Mixed trend on the daily chart: above its 200-day average, below its 50-day · 50-day above the 200-day · SuperTrend down since Oct 1 · below the Ichimoku cloud · RSI 58 · MACD above its signal
| 13.02 | 52-week high | +66.18% |
| 8.75 | Previous month high | +11.68% |
| 7.89 | R3 (classic) | +0.70% |
| 7.84 | Price now | |
| 7.75 | R2 (classic) | −1.08% |
| 7.70 | Previous week high | −1.72% |
| 7.66 | R1 (classic) | −2.23% |
| 7.62 | Previous month low | −2.74% |
| 7.61 | Previous day high | −2.87% |
| 7.52 | Pivot | −4.02% |
| 7.43 | S1 (classic) | −5.17% |
| 7.38 | Previous day low | −5.81% |
| 7.29 | S2 (classic) | −6.96% |
| 7.20 | S3 (classic) | −8.10% |
| 7.16 | Previous week low | −8.62% |
| 6.13 | 52-week low | −21.76% |
None of the 29 investors followed here reported a position in CRMD in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CRMD trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 3, 2026 | Zelnick Kaufman BethOfficer | Stock Award(Grant) at price 0.00 per share. | 36K | — |
| Feb 3, 2026 | Hurlburt ElizabethChief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 36K | — |
| Feb 3, 2026 | Todisco JosephChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 77.2K | — |
| Jan 25, 2026 | Lefkowitz Steven WDirector | Stock Award(Grant) at price 0.00 per share. | 30.5K | — |
| Jan 25, 2026 | Dunton Alan WilliamDirector | Stock Award(Grant) at price 0.00 per share. | 30.5K | — |
| Jan 25, 2026 | Stewart Robert ADirector | Stock Award(Grant) at price 0.00 per share. | 30.5K | — |
| Jan 25, 2026 | Dillione Janet MDirector | Stock Award(Grant) at price 0.00 per share. | 30.5K | — |
| Jan 25, 2026 | Kaplan MyronDirector | Stock Award(Grant) at price 0.00 per share. | 30.5K | — |
| Jan 25, 2026 | Duncan Gregory ScottDirector | Stock Award(Grant) at price 0.00 per share. | 30.5K | — |
| Jan 22, 2026 | Zelnick Kaufman BethOfficer | Stock Award(Grant) at price 0.00 per share. | 72.8K | — |
| Jan 22, 2026 | Hurlburt ElizabethChief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 93K | — |
| Jan 22, 2026 | Todisco JosephChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 225.9K | — |
| Jan 22, 2026 | Blum SusanChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 72.8K | — |
| Jan 20, 2026 | Dillione Janet MDirector | Sale at price 6.88 per share. | 10K | $68.80K |
| Jan 15, 2026 | Todisco JosephChief Executive Officer | Conversion of Exercise of derivative security at price 3.38 per share. | 29.6K | $100.00K |
| Jan 11, 2026 | Lefkowitz Steven WDirector | Conversion of Exercise of derivative security at price 5.63 per share. | 15K | $84.45K |
| Jan 7, 2026 | Seckler Michael DavidOfficer | Stock Award(Grant) at price 0.00 per share. | 133.2K | — |
| Dec 29, 2025 | Dunton Alan WilliamDirector | Conversion of Exercise of derivative security at price 4.03 per share. | 20K | $80.60K |
| Dec 29, 2025 | Dunton Alan WilliamDirector | Sale at price 13.00 per share. | 20K | $260.00K |
| Dec 17, 2025 | Todisco JosephChief Executive Officer | Conversion of Exercise of derivative security at price 4.43 per share. | 30K | $132.90K |
TimeframesUp on the hourly, mixed on the daily, weekly and monthly.
over a rising 21 EMA, 21 over 50
bouncing over the 21 EMA
bouncing over the 21 EMA
pulling back under the 21 EMA
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -33.3 | -8.1 | -4.8 | 11.8 | 11.2 | -7.0 | -4.1 | 9.7 | -6.8 | 1.8 | −32.6% | ||
| 2025 | 26.8 | 0.9 | -40.5 | 49.2 | 32.1 | 1.5 | -5.3 | 27.1 | -21.6 | -4.3 | -11.9 | 18.6 | +43.6% |
| 2024 | -21.5 | 20.0 | 19.8 | 24.1 | 0.2 | -17.8 | 5.8 | 36.2 | 29.5 | 24.5 | -2.0 | -17.8 | +115.4% |
| 2023 | 2.8 | -6.7 | 2.2 | 19.3 | -2.6 | -17.5 | 11.3 | -7.9 | -9.1 | -5.9 | -6.6 | 15.7 | −10.9% |
| 2022 | -7.0 | 15.4 | 12.3 | -37.2 | -5.8 | 24.1 | 33.1 | -34.0 | -19.8 | 8.5 | 35.5 | 1.4 | −7.3% |
| 2021 | 17.8 | 71.4 | -33.4 | -13.5 | -16.3 | -5.1 | -15.3 | 11.2 | -28.0 | 4.5 | 2.5 | -8.6 | −38.8% |
| 2020 | -12.8 | -18.1 | -31.0 | 15.6 | 6.5 | 42.5 | -29.4 | 4.9 | 29.1 | -16.3 | 78.2 | -17.4 | +2.1% |
| 2019 | 55.8 | -18.4 | 15.2 | -14.3 | -20.7 | 39.7 | 8.0 | -20.7 | -16.9 | -12.5 | 9.9 | 18.8 | +12.9% |
| 2018 | -6.0 | -38.3 | -37.9 | 33.3 | -4.2 | 4.3 | 150.0 | 3.3 | 56.5 | 11.3 | 22.2 | -2.3 | +158.0% |
| 2017 | 8.5 | 25.3 | -21.6 | -60.7 | -37.5 | 7.5 | -14.0 | 35.1 | 4.0 | 5.8 | 7.3 | -15.3 | −67.3% |
| 2016 | -12.3 | -11.8 | 68.8 | 57.7 | -32.3 | -29.7 | -25.1 | 32.2 | 27.9 | -17.1 | -19.1 | -9.5 | −24.6% |
| 2015 | 62.3 | 66.5 | 90.7 | -23.8 | -18.8 | -36.3 | -9.8 | -21.7 | -27.4 | 27.6 | -5.5 | -15.4 | +6.3% |
| 2014 | 83.1 | 22.9 | -10.0 | -26.7 | -18.5 | 20.7 | 10.5 | 0.0 | -6.0 | -3.2 | -23.1 | 36.4 | +54.0% |
| 2013 | 29.2 | -8.6 | -4.7 | -25.9 | -11.7 | 79.2 | 0.0 | 6.3 | -8.9 | -10.9 | -2.4 | 55.0 | +72.2% |
| 2012 | 21.4 | 2.9 | 34.3 | -21.3 | -45.9 | 5.0 | 9.5 | -21.7 | 44.4 | 123.1 | 24.1 | 0.0 | +157.1% |
| 2011 | 0.5 | -9.3 | 7.8 | 4.5 | -8.6 | -15.2 | -10.3 | -28.5 | -2.2 | -53.8 | -23.8 | -12.5 | −84.6% |
| 2010 | -18.8 | -34.1 | 20.7 | -9.7 | -11.4 | -10.7 | 45.6 | −32.8% |
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Buy / hold / sell counts